LENSAR, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: LNSR · Form: DEF 14A · Filed: Mar 25, 2024 · CIK: 1320350
| Field | Detail |
|---|---|
| Company | Lensar, Inc. (LNSR) |
| Form Type | DEF 14A |
| Filed Date | Mar 25, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: LENSAR, Annual Meeting, Proxy Statement, Stockholders, Virtual Meeting
TL;DR
<b>LENSAR, Inc. is holding its 2024 virtual Annual Meeting of Stockholders on May 7, 2024, urging shareholders to vote.</b>
AI Summary
LENSAR, Inc. (LNSR) filed a Proxy Statement (DEF 14A) with the SEC on March 25, 2024. LENSAR, Inc. will hold its 2024 Annual Meeting of Stockholders on May 7, 2024, at 11:00 a.m. Eastern Time. The meeting will be conducted virtually via live webcast. Stockholders of record as of March 11, 2024, will receive a Notice of Internet Availability of Proxy Materials. The company encourages stockholders to vote their shares electronically, by telephone, or by mail. Voting online during the Annual Meeting is also an option for attendees.
Why It Matters
For investors and stakeholders tracking LENSAR, Inc., this filing contains several important signals. The virtual format allows for broader participation and reduces logistical costs associated with in-person meetings. The company emphasizes the importance of shareholder voting to ensure representation and facilitate corporate governance decisions.
Risk Assessment
Risk Level: low — LENSAR, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no new material financial or operational information presented.
Analyst Insight
Stockholders should review the proxy materials and vote their shares prior to the May 7, 2024, meeting to ensure their voice is heard on corporate matters.
Key Numbers
- 2024 — Annual Meeting Year (2024 Annual Meeting of Stockholders)
- May 7 — Meeting Date (Date of Annual Meeting)
- 11:00 a.m. Eastern Time — Meeting Time (Start time of Annual Meeting)
- March 11, 2024 — Record Date (Stockholders of record date)
Key Players & Entities
- LENSAR, Inc. (company) — Registrant
- May 7, 2024 (date) — Date of Annual Meeting
- March 11, 2024 (date) — Record date for stockholders
- Orlando, Florida (location) — Company Headquarters
FAQ
When did LENSAR, Inc. file this DEF 14A?
LENSAR, Inc. filed this Proxy Statement (DEF 14A) with the SEC on March 25, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by LENSAR, Inc. (LNSR).
Where can I read the original DEF 14A filing from LENSAR, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by LENSAR, Inc..
What are the key takeaways from LENSAR, Inc.'s DEF 14A?
LENSAR, Inc. filed this DEF 14A on March 25, 2024. Key takeaways: LENSAR, Inc. will hold its 2024 Annual Meeting of Stockholders on May 7, 2024, at 11:00 a.m. Eastern Time.. The meeting will be conducted virtually via live webcast.. Stockholders of record as of March 11, 2024, will receive a Notice of Internet Availability of Proxy Materials..
Is LENSAR, Inc. a risky investment based on this filing?
Based on this DEF 14A, LENSAR, Inc. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no new material financial or operational information presented.
What should investors do after reading LENSAR, Inc.'s DEF 14A?
Stockholders should review the proxy materials and vote their shares prior to the May 7, 2024, meeting to ensure their voice is heard on corporate matters. The overall sentiment from this filing is neutral.
How does LENSAR, Inc. compare to its industry peers?
LENSAR, Inc. operates in the medical device industry, specifically focusing on ophthalmic surgical equipment.
Are there regulatory concerns for LENSAR, Inc.?
The filing is made under Rule 14a-101 of the Securities Exchange Act of 1934, which governs the content of proxy statements.
Industry Context
LENSAR, Inc. operates in the medical device industry, specifically focusing on ophthalmic surgical equipment.
Regulatory Implications
The filing is made under Rule 14a-101 of the Securities Exchange Act of 1934, which governs the content of proxy statements.
What Investors Should Do
- Review the proxy statement for proposals and voting matters.
- Vote shares by the deadline, using the provided electronic, telephone, or mail options.
- Attend the virtual meeting on May 7, 2024, to participate in real-time.
Key Dates
- 2024-05-07: 2024 Annual Meeting of Stockholders — Key date for shareholder voting and participation.
- 2024-03-11: Record Date — Determines which stockholders are eligible to receive proxy materials and vote.
- 2024-03-25: Filing Date — Date the definitive proxy statement was filed with the SEC.
Year-Over-Year Comparison
This is a routine DEF 14A filing for the annual meeting, providing procedural information rather than new financial or operational updates compared to previous filings.
Filing Stats: 4,721 words · 19 min read · ~16 pages · Grade level 11.5 · Accepted 2024-03-25 06:03:06
Filing Documents
- lnsr-proxy-2024.htm (DEF 14A) — 908KB
- img37589739_0.jpg (GRAPHIC) — 62KB
- img37589739_1.jpg (GRAPHIC) — 62KB
- img37589739_2.jpg (GRAPHIC) — 62KB
- img37589739_3.jpg (GRAPHIC) — 424KB
- img37589739_4.jpg (GRAPHIC) — 188KB
- 0000950170-24-035579.txt ( ) — 1995KB
Security Ownership of Certain Beneficial Owners and Management
Security Ownership of Certain Beneficial Owners and Management 30 Delinquent Section 16(a) Reports 32 CERTAIN TRANSACTIONS WITH RELATED PERSONS 34 Policies and Procedures on Transactions with Related Persons 34 North Run Investment 34 Indemnification Agreements 34 STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS 35 HOUSEHOLDING 35 2023 ANNUAL REPORT 36 ii LENSAR, Inc. 2800 Discovery Drive Orlando, Florida 32826 PROXY STATEMENT FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 7, 2024 This proxy statement (the “Proxy Statement”) and our annual report for the fiscal year ended December 31, 2023 (the “Annual Report” and, together with this Proxy Statement, the “proxy materials”) are being furnished by and on behalf of the board of directors (the “Board” or “Board of Directors”) of LENSAR, Inc. (the “Company,” “LENSAR,” “we,” “us,” or “our”), in connection with our 2024 annual meeting of stockholders (the “Annual Meeting”). The Notice of Annual Meeting and this Proxy Statement are first being distributed or made available, as the case may be, on or about March 25, 2024. GENERAL INFORMATION ABOUT TH E ANNUAL MEETING AND VOTING When and where will the Annual Meeting be held? The Annual Meeting will be held on Tuesday, May 7, 2024 at 11:00 a.m., Eastern Time. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. You will be able to attend the Annual Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/LNSR2024 and entering your 16-digit control number included in your Notice of Internet Availability of Proxy Materials, on your proxy card or on the instructions that accompanied your proxy materials. If you lose your 16-digit control number, you may join the Annual Me